Publications in collaboration with researchers from Universidade de Santiago de Compostela (84)

2024

  1. Skin Rash During Epstein-Barr Virus-Induced Infectious Mononucleosis in Adolescents and Adults: Incidence, Predisposing Factors, and Prognostic Implications

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 118-120

2023

  1. Are corticosteroids safe in adolescent and adult patients with infectious mononucleosis? A retrospective cohort study

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  3. Hematological Abnormalities Beyond Lymphocytosis During Infectious Mononucleosis: Epstein-Barr Virus-Induced Thrombocytopenia

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 15, Núm. 1

  4. Jaundice in relation to immune activation during Epstein-Barr virus-induced infectious mononucleosis

    American Journal of the Medical Sciences, Vol. 365, Núm. 3, pp. 270-278

2022

  1. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

2020

  1. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

  2. Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (Scientific Reports, (2020), 10, 1, (3355), 10.1038/s41598-020-60305-x)

    Scientific Reports

2017

  1. Acute focal bacterial nephritis in a cohort of hospitalized adult patients with acute pyelonephritis. Assessment of risk factors and a predictive model

    European Journal of Internal Medicine, Vol. 39, pp. 69-74

  2. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients

    PLoS ONE, Vol. 12, Núm. 7

2016

  1. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies

    PLoS ONE, Vol. 11, Núm. 8

  2. Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study

    PLoS ONE, Vol. 11, Núm. 4

  3. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140

2015

  1. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  2. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

    Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391

  3. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors

    Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345

  4. Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  5. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis

    European Journal of Pharmacology, Vol. 765, pp. 228-233

2014

  1. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

    Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245

  2. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3